LMRI Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
["Not a good buy right now: price is in a strong downtrend (SMA_200 > SMA_20 > SMA_5) with bearish momentum still intact.", "RSI_6 at ~4.9 is extremely oversold, so a short-term bounce is possible, but without a confirmed reversal or proprietary buy signal this is a low-quality entry for an impatient buyer (higher odds of further downside before any durable rebound).", "Intellectia Proprietary Trading Signals\n- AI Stock Picker: no signal on given stock today.\n- SwingMax: No signal on given stock recently.", "Wall Street is broadly bullish on the story (multiple Buy/Outperform initiations with ~$22\u2013$23 targets), but the tape is currently disagreeing; for \u201cbuy now\u201d timing, technicals dominate here."]
["Trend: Bearish (SMA_200 > SMA_20 > SMA_5), indicating persistent downside pressure across short-, medium-, and long-term timeframes.", "Momentum: MACD histogram -0.524 (below zero) and only \u201cnegatively contracting\u201d \u2014 downside momentum may be slowing, but it has not flipped bullish.", "Oversold: RSI_6 = 4.878 (extreme oversold). This often precedes a reflex rally, but it\u2019s not a standalone buy signal in a strong downtrend.", "Key levels: Current price 10.8 is below S1 (11.384) and near S2 (10.289). A breakdown below ~10.29 would be a clear bearish continuation. Upside resistance starts near Pivot 13.155, then ~14.927."]
["Analyst sentiment catalyst: broad, same-day coverage initiations (Buy/Overweight/Outperform) with ~$22\u2013$23 price targets can support longer-term investor interest.", "Sector tailwinds cited by analysts: shift to lower-cost outpatient sites, chronic disease/demographic demand, higher advanced imaging mix, new center openings.", "Technical mean-reversion potential: extremely oversold RSI increases odds of a short-term bounce if selling pressure exhausts near ~10.3 support."]
["Price action is clearly risk-off today: -2.68% in regular session while S&P 500 is -0.78% (relative weakness).", "No confirming buy signals: Intellectia AI Stock Picker and SwingMax show no current/recent buy signals.", "Event flow: no news in the last week to spark a positive re-rating or reversal catalyst.", "Positioning/flows: hedge funds and insiders reported as neutral (no supportive buying pressure visible from these groups)."]
["Latest quarter: 2024/Q4.", "Revenue: 248.028M, reported as 0.00% YoY growth (flat).", "Profitability: Net income -25.058M (still a loss) and EPS -0.19; the data shows 0.00% YoY change, implying no visible improvement trend in the snapshot provided.", "Margins: Gross margin 11.58% (low for a business needing operating leverage to drive a sustained equity re-rate)."]
["Recent trend: strong positive shift via multiple initiations on 2026-01-05 (Deutsche Bank Buy $22; Barclays Overweight $23; Jefferies Buy $23; Wells Fargo Overweight $22; Raymond James Outperform $23; Leerink Outperform $23; William Blair Outperform).", "Pros (Wall St view): secular imaging demand tailwinds, outpatient shift, advanced imaging mix growth, new center openings, potential multi-year EBITDA growth and deleveraging story.", "Cons (Wall St view, implied vs. current tape): despite bullish long-term narratives and targets, the stock is trading with heavy bearish technicals and weak near-term sentiment, making timing unfavorable for an immediate buy."]
